Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 4, 2010, Pages 655-661

  Lazǎr, Daniela ^a   Tǎban, Sorina ^a   Sporea, I ^a   Dema, Alis ^a   Cornianu, Mǎrioara ^a   Lazǎr, Elena ^a   Goldis A ^a   Vernic, Corina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Clinicopathological factors; Gastric cancer; Ki 67; Survival

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 78649948248     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DE MANZONI G, VERLATO G, TOMEZZOLI A, GUGLIELMI A, PELOSI G, RICCI F, DI LEO A, CORDIANO C, Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer, Jpn J Clin Oncol, 1998, 28(9):534-537.
2. OHYAMA S, YONEMURA Y, MIYAZAKI I, Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application, Cancer, 1992, 69(2):314-321.
3. TANIGAWA N, MASUDA Y, SHIMOMATSUYA T, FUJII H, MURAOKA R, TANAKA T, Thymidine uptake in vitro as a prognostic indicator for primary gastric cancer, Cancer, 1993, 72(10):2883-2888.
4. CATTORETTI G, BECKER MH, KEY G, DUCHROW M, SCHLÜTER C, GALLE J, GERDES J, Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwaveprocessed formalin-fixed paraffin sections, J Pathol, 1992, 168(4):357-363.
5. KEY G, BECKER MH, DUCHROW M, SCHLÜTER C, FLAD HD, GERDES J, New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of the Ki-67 antigen, Anal Cell Pathol, 1992, 4:181-185.
6. LAZAREV AF, KLIMACHEV VV, AVDALIAN AM, BOBROV IP, ZOR'KIN VT, Ki-67 and p53 expression in gastric dysplasias and cancer, Arkh Patol, 2006, 68(3):6-10.
7. WANG L, ZHENG L, WANG SY, ZHU TF, ZHU HG, Clonal analysis of gastric carcinoma and precancerous lesions and its relation to Ki-67 protein expression, Neoplasma, 2009, 56(1):48-55.
8. KOMAROV FI, OSADCHUK AM, OSADCHUK MA, KOGAN NIU, Kveshnoǐ IM, Specifics of apoptotic activity and expression of regulatory molecules (Ki-67, Bcl-2) of gastric mucosal epitheliocytes, in the process of Correa's cascade, Klin Med (Mosk), 2007, 85(10):48-51.
9. ZHENG Y, WANG L, ZHANG JP, YANG JY, ZHAO ZM, ZHANG XY, Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma, World J Gastroenterol, 2010, 16(3):339-344.
10. MǍRGǍRITESCU C, MOGOANTǍ L, MǍNESCU P, SIMIONESCU C, PIRICI D, STREBA L, MERCUŢ D, The immunohistochemical profile of the adenocarcinoma of upper gastric pole, Rom J Morphol Embryol, 2007, 48(3):215-235.
11. MÜLLER W, SCHNEIDERS A, MEIER S, HOMMEL G, GABBERT HE, Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma, Br J Cancer, 1996, 74(5):759-765.
12. INADA T, IMURA J, ICHIKAWA A, OGATA Y, SHIMAMURA K, Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen, J Surg Oncol, 1993, 54(3):146-151; discussion 151-152.
13. VAN DER WOUDE CJ, KLEIBEUKER JH, TIEBOSCH AT, HOMAN M, BEUVING A, JANSEN PL, MOSHAGE H, Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins, J Clin Pathol, 2003, 56(9):699-702.
14. KIKUYAMA S, KUBOTA T, SHIMIZU K, MIYAKITA M, Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer, Oncol Rep, 1998, 5(4):867-870.
15. ZHENG HC, ZHENG YS, XIA P, XU XY, XING YN, TAKAHASHI H, GUAN YF, TAKANO Y, The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes, Histol Histopathol, 2010, 25(4):445-452.
16. CHEN L, LI X, WANG GL, WANG Y, ZHU YY, ZHU J, Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma, Tumori, 2008, 94(4):531-538.
17. CZYZEWSKA J, GUZIŃSKA-USTYMOWICZ K, PRYCZYNICZ A, KEMONA A, BANDURSKI R, Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer, Folia Histochem Cytobiol, 2009, 47(2):289-296.
18. ELPEK GO, GELEN T, AKSOY NH, KARPUZOGLU T, KELES N, Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma, Pathol Oncol Res, 2000, 6(1):59-64.
19. JOO YE, CHUNG IJ, PARK YK, KOH YS, LEE JH, PARK CH, LEE WS, KIM HS, CHOI SK, REW JS, PARK CS, KIM SJ, Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer, J Korean Med Sci, 2006, 21(5):871-876.
20. MATTIOLI E, VOGIATZI P, SUN A, ABBADESSA G, ANGELONI G, D'UGO D, TRANI D, GAUGHAN JP, VECCHIO FM, CEVENINI G, PERSIANI R, GIORDANO A, CLAUDIO PP, Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16 (INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer, J Cell Physiol, 2007, 210(1):183-191.
21. LEE KH, LEE HE, CHO SJ, CHO YJ, LEE HS, KIM JH, NAM SY, CHANG MS, KIM WH, LEE BL, Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis, Pathobiology, 2008, 75(6):364-372.
22. BROLL R, MAHLKE C, BEST R, SCHIMMELPENNING H, STRIK MW, SCHIEDECK T, BRUCH HP, DUCHROW M, Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1, J Cancer Res Clin Oncol, 1998, 124(1):49-54.
23. MAEDA K, CHUNG YS, ONODA N, KATO Y, NITTA A, ARIMOTO Y, YAMADA N, KONDO Y, SOWA M, Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis, Cancer, 1994, 73(3):528-533.
24. MANGHAM DC, ROWLANDS DC, NEWBOLD KM, REYNOLDS GM, FIELDING JW, HALLISSEY MT, Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value, J Clin Pathol, 1994, 47(5):473-474.
25. IGARASHI N, TAKAHASHI M, OHKUBO H, OMATA K, IIDA R, FUJIMOTO S, Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma, Cancer, 1999, 86(8):1449-1454.
26. MORI M, KAKEJI Y, ADACHI Y, MORIGUCHI S, MAEHARA Y, SUGIMACHI K, JESSUP JM, CHEN LB, STEELE GD JR, The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer, Surgery, 1993, 113(6):683-690.
27. MAEDA K, CHUNG YS, TAKATSUKA S, OGAWA Y, ONODA N, SAWADA T, KATO Y, NITTA A, ARIMOTO Y, KONDO Y, et al., Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma, Br J Cancer, 1995, 72(2):319-323.
28. VICTORZON M, ROBERTS PJ, HAGLUND C, VON BOGUSLAWSKY K, NORDLING S, Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma, Oncology, 1996, 53(3):182-191.
29. TSAMANDAS AC, KARDAMAKIS D, TSIAMALOS P, LIAVA A, TZELEPI V, VASSILIOU V, PETSAS T, VAGENAS K, ZOLOTA V, SCOPA CD, The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome, Anticancer Res, 2009, 29(2):703-709.
30. BRIEN TP, DEPOWSKI PL, SHEEHAN CE, ROSS JS, MCKENNA BJ, Prognostic factors in gastric cancer, Mod Pathol, 1998, 11:870-877.